Literature DB >> 27690420

New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.

Louis Zimmermann1, Indrajit Das1, Jérôme Désiré1, Guillaume Sautrey2, Vinicius Barros R S1, Micheline El Khoury2, Marie-Paule Mingeot-Leclercq2, Jean-Luc Décout1.   

Abstract

Aminoglycosides (AGs) constitute a major family of potent and broad-spectrum antibiotics disturbing protein synthesis through binding to the A site of 16S rRNA. Decades of widespread clinical use of AGs strongly reduced their clinical efficacy through the selection of resistant bacteria. Recently, conjugation of lipophilic groups to AGs generated a novel class of potent antibacterial amphiphilic aminoglycosides (AAGs) with significant improved activities against various sensitive and resistant bacterial strains. We have identified amphiphilic 3',6-dialkyl derivatives of the small aminoglycoside neamine as broad spectrum antibacterial agents targeting bacterial membranes. Here, we report on the synthesis and the activity against sensitive and resistant Gram-negative and/or Gram-positive bacteria of new amphiphilic 3',4'-dialkyl neamine derivatives and of their smaller analogues in the 6-aminoglucosamine (neosamine) series prepared from N-acetylglucosamine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27690420     DOI: 10.1021/acs.jmedchem.6b00818

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

2.  Targeting Bacterial Cardiolipin Enriched Microdomains: An Antimicrobial Strategy Used by Amphiphilic Aminoglycoside Antibiotics.

Authors:  Micheline El Khoury; Jitendriya Swain; Guillaume Sautrey; Louis Zimmermann; Patrick Van Der Smissen; Jean-Luc Décout; Marie-Paule Mingeot-Leclercq
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 3.  Amikacin: Uses, Resistance, and Prospects for Inhibition.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

4.  Effect of cardiolipin on the antimicrobial activity of a new amphiphilic aminoglycoside derivative on Pseudomonas aeruginosa.

Authors:  Jitendriya Swain; Micheline El Khoury; Julie Kempf; Florian Briée; Patrick Van Der Smissen; Jean-Luc Décout; Marie-Paule Mingeot-Leclercq
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

Review 5.  Amphiphilic Aminoglycosides as Medicinal Agents.

Authors:  Clément Dezanet; Julie Kempf; Marie-Paule Mingeot-Leclercq; Jean-Luc Décout
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

6.  A dual enhanced anti-bacterial strategy based on high chlorin e6-loaded polyethyleneimine functionalized graphene.

Authors:  Jiangxia Wang; Yuting Yang; Yuanliang Xu; Lifeng Zhao; Lu Wang; Zhengzhi Yin; Huiming Li; Huan Tan; Kunping Liu
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

7.  Bioactive silver phosphate/polyindole nanocomposites.

Authors:  Soumik Podder; Samrat Paul; Piyali Basak; Bowen Xie; Nigel J Fullwood; Sara J Baldock; Ying Yang; John G Hardy; Chandan K Ghosh
Journal:  RSC Adv       Date:  2020-03-17       Impact factor: 4.036

Review 8.  Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.

Authors:  Charlotte M J Wesseling; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578

Review 9.  Amphiphilic aminoglycosides: Modifications that revive old natural product antibiotics.

Authors:  Jon Y Takemoto; Guillermo A Altenberg; Naveena Poudyal; Yagya P Subedi; Cheng-Wei T Chang
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

10.  Synthesis of Ring II/III Fragment of Kanamycin: A New Minimum Structural Motif for Aminoglycoside Recognition.

Authors:  Sandra G Zárate; Agatha Bastida; Andrés G Santana; Julia Revuelta
Journal:  Antibiotics (Basel)       Date:  2019-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.